Login
| TI Ref No : | 524286385 |
|---|---|
| Description : | The Dak-gesundheit Intends To Conclude A Non-exclusive Discount Agreement According To ยง 130a Abs. 8 Sgb V For The Active Ingredient Tocilizumab (only Pre-filled Syringe And Pre-filled Pen), Atc L04ac07 For The Period From 01.12.2025 To 30.11.2027. This I |
| Date : | 2025-10-25 |
| Deadline : | 2026-04-22 |
| Document Type : | Tenders |
